Stryker Historical Income Statement

SYK Stock

USD 388.14 1.57 0.40%

Historical analysis of Stryker income statement accounts such as Other Operating Expenses of 17.4 B, Operating Income of 4.1 B, EBIT of 4.1 B or Ebitda of 5.2 B can show how well Stryker performed in making a profits. Evaluating Stryker income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Stryker's future profits or losses.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Stryker latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Stryker is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

About Stryker Income Statement Analysis

Stryker Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Stryker shareholders. The income statement also shows Stryker investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Stryker Income Statement Chart

At this time, Stryker's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 4.1 B this year, although the value of Non Operating Income Net Other will most likely fall to (149.3 M).

Total Revenue Gross Profit Operating Income Ebitda

Total Revenue

Total revenue comprises all receipts Stryker generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Stryker minus its cost of goods sold. It is profit before Stryker operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Operating Income

Operating Income is the amount of profit realized from Stryker operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Stryker is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Stryker's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Stryker current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Stryker. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.At this time, Stryker's Operating Income is quite stable compared to the past year. EBIT is expected to rise to about 4.1 B this year, although the value of Non Operating Income Net Other will most likely fall to (149.3 M).

	2021	2022	2023	2024 (projected)
Gross Profit	11.0B	11.6B	13.1B	13.8B
Total Revenue	17.1B	18.4B	20.5B	21.5B

Gross Profit Total Revenue

Stryker income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Research Development	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Selling And Marketing Expenses	Minority Interest	Tax Provision	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.71	0.67	0.65	0.69	0.58	0.41	0.64	0.7	0.68	0.58	0.0	0.43	0.25	0.64	0.71	0.25	0.29	-0.23	-0.54	-0.54	0.16	0.58	0.81
Interest Expense	0.71		0.77	0.76	0.78	0.73	0.68	0.78	0.8	0.76	0.71	-0.09	0.57	0.22	0.75	0.79	0.43	0.47	-0.47	-0.58	-0.58	0.18	0.73	0.86
Total Revenue	0.67	0.77		1.0	1.0	0.96	0.92	0.97	1.0	0.99	0.95	-0.36	0.83	0.14	0.99	0.98	0.6	0.75	-0.63	-0.59	-0.59	0.02	0.81	0.84
Gross Profit	0.65	0.76	1.0		1.0	0.97	0.92	0.97	0.99	0.99	0.95	-0.37	0.83	0.14	0.99	0.98	0.6	0.76	-0.63	-0.59	-0.59	0.01	0.8	0.82
Other Operating Expenses	0.69	0.78	1.0	1.0		0.94	0.9	0.96	1.0	1.0	0.93	-0.34	0.81	0.14	0.99	0.99	0.59	0.76	-0.63	-0.57	-0.57	0.02	0.82	0.85
Operating Income	0.58	0.73	0.96	0.97	0.94		0.93	0.96	0.95	0.93	1.0	-0.38	0.88	0.12	0.96	0.92	0.65	0.67	-0.55	-0.68	-0.68	0.0	0.75	0.76
Ebit	0.41	0.68	0.92	0.92	0.9	0.93		0.96	0.91	0.89	0.91	-0.55	0.82	0.08	0.91	0.89	0.65	0.69	-0.74	-0.43	-0.43	0.0	0.79	0.69
Ebitda	0.64	0.78	0.97	0.97	0.96	0.96	0.96		0.97	0.95	0.94	-0.47	0.82	0.14	0.95	0.96	0.62	0.67	-0.69	-0.52	-0.52	0.05	0.83	0.82
Cost Of Revenue	0.7	0.8	1.0	0.99	1.0	0.95	0.91	0.97		0.99	0.94	-0.34	0.82	0.14	0.98	0.99	0.6	0.74	-0.62	-0.59	-0.59	0.03	0.83	0.87
Total Operating Expenses	0.68	0.76	0.99	0.99	1.0	0.93	0.89	0.95	0.99		0.92	-0.34	0.8	0.14	0.99	0.98	0.57	0.78	-0.64	-0.55	-0.55	0.01	0.8	0.83
Income Before Tax	0.58	0.71	0.95	0.95	0.93	1.0	0.91	0.94	0.94	0.92		-0.33	0.89	0.12	0.95	0.9	0.65	0.64	-0.48	-0.7	-0.7	0.0	0.71	0.75
Total Other Income Expense Net	0.0	-0.09	-0.36	-0.37	-0.34	-0.38	-0.55	-0.47	-0.34	-0.34	-0.33		-0.23	-0.17	-0.35	-0.33	-0.14	-0.54	0.76	0.0	0.0	-0.17	-0.44	-0.08
Net Income	0.43	0.57	0.83	0.83	0.81	0.88	0.82	0.82	0.82	0.8	0.89	-0.23		-0.36	0.83	0.79	0.88	0.55	-0.43	-0.57	-0.57	-0.45	0.61	0.67
Income Tax Expense	0.25	0.22	0.14	0.14	0.14	0.12	0.08	0.14	0.14	0.14	0.12	-0.17	-0.36		0.12	0.13	-0.57	0.1	-0.06	-0.18	-0.18	0.95	0.11	0.06
Selling General Administrative	0.64	0.75	0.99	0.99	0.99	0.96	0.91	0.95	0.98	0.99	0.95	-0.35	0.83	0.12		0.96	0.59	0.77	-0.61	-0.59	-0.59	0.0	0.77	0.79
Research Development	0.71	0.79	0.98	0.98	0.99	0.92	0.89	0.96	0.99	0.98	0.9	-0.33	0.79	0.13	0.96		0.6	0.74	-0.63	-0.55	-0.55	0.03	0.85	0.9
Net Income From Continuing Ops	0.25	0.43	0.6	0.6	0.59	0.65	0.65	0.62	0.6	0.57	0.65	-0.14	0.88	-0.57	0.59	0.6		0.36	-0.35	-0.26	-0.26	-0.56	0.59	0.62
Non Recurring	0.29	0.47	0.75	0.76	0.76	0.67	0.69	0.67	0.74	0.78	0.64	-0.54	0.55	0.1	0.77	0.74	0.36		-0.66	-0.39	-0.39	0.0	0.59	0.5
Non Operating Income Net Other	-0.23	-0.47	-0.63	-0.63	-0.63	-0.55	-0.74	-0.69	-0.62	-0.64	-0.48	0.76	-0.43	-0.06	-0.61	-0.63	-0.35	-0.66		0.02	0.02	-0.02	-0.76	-0.44
Selling And Marketing Expenses	-0.54	-0.58	-0.59	-0.59	-0.57	-0.68	-0.43	-0.52	-0.59	-0.55	-0.7	0.0	-0.57	-0.18	-0.59	-0.55	-0.26	-0.39	0.02		1.0	-0.07	-0.35	-0.52
Minority Interest	-0.54	-0.58	-0.59	-0.59	-0.57	-0.68	-0.43	-0.52	-0.59	-0.55	-0.7	0.0	-0.57	-0.18	-0.59	-0.55	-0.26	-0.39	0.02	1.0		-0.07	-0.35	-0.52
Tax Provision	0.16	0.18	0.02	0.01	0.02	0.0	0.0	0.05	0.03	0.01	0.0	-0.17	-0.45	0.95	0.0	0.03	-0.56	0.0	-0.02	-0.07	-0.07		0.12	0.04
Interest Income	0.58	0.73	0.81	0.8	0.82	0.75	0.79	0.83	0.83	0.8	0.71	-0.44	0.61	0.11	0.77	0.85	0.59	0.59	-0.76	-0.35	-0.35	0.12		0.85
Reconciled Depreciation	0.81	0.86	0.84	0.82	0.85	0.76	0.69	0.82	0.87	0.83	0.75	-0.08	0.67	0.06	0.79	0.9	0.62	0.5	-0.44	-0.52	-0.52	0.04	0.85

Click cells to compare fundamentals

Stryker Account Relationship Matchups

Stryker income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	171.9K	812M	990M	998M	1.0B	1.1B
Interest Expense	287M	315M	337M	158M	356M	373.8M
Total Revenue	14.9B	14.4B	17.1B	18.4B	20.5B	21.5B
Gross Profit	9.7B	9.1B	11.0B	11.6B	13.1B	13.8B
Other Operating Expenses	12.0B	12.1B	14.4B	15.4B	16.6B	17.4B
Operating Income	2.7B	2.2B	2.6B	2.8B	3.9B	4.1B
Ebit	3.9B	2.9B	3.7B	3.5B	3.9B	4.1B
Ebitda	3.9B	3.8B	4.6B	4.5B	4.9B	5.2B
Cost Of Revenue	5.2B	5.3B	6.1B	6.9B	7.4B	7.8B
Total Operating Expenses	6.8B	6.8B	8.3B	8.5B	9.2B	9.7B
Income Before Tax	2.6B	2.0B	2.3B	2.7B	3.7B	3.9B
Total Other Income Expense Net	(151M)	(269M)	(303M)	(158M)	(215M)	(204.3M)
Net Income	2.1B	1.6B	2.0B	2.4B	3.2B	3.3B
Income Tax Expense	479M	355M	287M	325M	508M	533.4M
Selling General Administrative	5.4B	5.4B	5.8B	6.0B	7.1B	7.5B
Research Development	971M	984M	1.2B	1.5B	1.4B	1.5B
Net Income Applicable To Common Shares	2.1B	1.6B	2.0B	2.4B	2.7B	2.8B
Net Income From Continuing Ops	2.1B	1.6B	2.0B	2.4B	3.2B	1.9B
Non Operating Income Net Other	(151M)	(269M)	(303M)	(158M)	(142.2M)	(149.3M)
Tax Provision	479M	355M	287M	325M	508M	289.7M
Interest Income	125M	213M	269M	243M	279.5M	192.8M
Reconciled Depreciation	778M	812M	990M	998M	1.0B	938.3M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:

How To Invest In Stryker

Details

Is Stryker Stock a good investment?

Details

What is Stryker's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.2

Dividend Share

3.2

Earnings Share

9.31

Revenue Per Share

57.728

Quarterly Revenue Growth

0.119

The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Stryker Historical Income Statement

About Stryker Income Statement Analysis

Stryker Income Statement Chart

Total Revenue

Gross Profit

Operating Income

Stryker income statement Correlations

Stryker Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Stryker income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Cost Of Revenue	+ 1.0	Other Operating Expenses
Total Operating Expenses	+ 1.0	Other Operating Expenses

Interest Income	- 0.76	Non Operating Income Net Other
Non Operating Income Net Other	- 0.74	Ebit
Minority Interest	- 0.7	Income Before Tax
Selling And Marketing Expenses	- 0.7	Income Before Tax
Non Operating Income Net Other	- 0.69	Ebitda
Minority Interest	- 0.68	Operating Income